SS
IRWD icon

Sunbelt Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

Sunbelt Securities’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56K Hold
444
– – ﹤0.01% 1986
2025
Q4 		$1.5K Hold
444
– – ﹤0.01% 1954
2025
Q3 		$582 Buy
+444
New +$460 ﹤0.01% 2186

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sunbelt Securities's IRWD Position: Q1 2026 in Review

Sunbelt Securities held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 444 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Sunbelt Securities first reported a position in IRWD in Q3 2025 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Sunbelt Securities held 444 shares of Ironwood Pharmaceuticals worth $1.56K as of Q1 2026.
  • Sunbelt Securities left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1986 holding.
  • Sunbelt Securities first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.